X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16465) 16465
Book Review (4938) 4938
Publication (1143) 1143
Book Chapter (118) 118
Conference Proceeding (57) 57
Newsletter (57) 57
Book / eBook (22) 22
Dissertation (14) 14
Magazine Article (6) 6
Web Resource (4) 4
Trade Publication Article (2) 2
Paper (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14742) 14742
humans (10039) 10039
animals (7801) 7801
renin-angiotensin system (7515) 7515
renin-angiotensin system - drug effects (7276) 7276
male (7089) 7089
female (4425) 4425
rats (4147) 4147
hypertension (3998) 3998
renin-angiotensin system - physiology (3642) 3642
blood pressure - drug effects (3519) 3519
hypertension - drug therapy (2831) 2831
angiotensin (2618) 2618
middle aged (2597) 2597
peripheral vascular disease (2588) 2588
angiotensin-converting enzyme inhibitors - therapeutic use (2472) 2472
blood-pressure (2338) 2338
adult (2221) 2221
hypertension - physiopathology (2126) 2126
pharmacology & pharmacy (1960) 1960
blood pressure (1902) 1902
cardiac & cardiovascular systems (1831) 1831
angiotensin-converting enzyme inhibitors - pharmacology (1816) 1816
aged (1719) 1719
antihypertensive agents - therapeutic use (1668) 1668
urology & nephrology (1568) 1568
physiology (1501) 1501
renin - blood (1476) 1476
angiotensin ii (1400) 1400
risk factors (1357) 1357
abridged index medicus (1325) 1325
renin (1235) 1235
mice (1204) 1204
kidney - drug effects (1180) 1180
rats, sprague-dawley (1139) 1139
oxidative stress (1113) 1113
angiotensin ii - pharmacology (1100) 1100
antihypertensive agents - pharmacology (1098) 1098
treatment outcome (1080) 1080
disease models, animal (1005) 1005
angiotensin ii type 1 receptor blockers - therapeutic use (992) 992
expression (964) 964
physiological aspects (951) 951
time factors (949) 949
aldosterone (946) 946
heart failure - drug therapy (946) 946
research (942) 942
angiotensin receptor antagonists (941) 941
drug therapy, combination (939) 939
heart failure (927) 927
endocrinology & metabolism (866) 866
blood pressure - physiology (849) 849
rats, wistar (848) 848
dose-response relationship, drug (842) 842
angiotensin ii type 1 receptor blockers - pharmacology (840) 840
medicine & public health (831) 831
hemodynamics - drug effects (816) 816
losartan (809) 809
ace inhibitors (806) 806
aldosterone - blood (798) 798
angiotensin ii - metabolism (797) 797
captopril - pharmacology (793) 793
diabetes (773) 773
system (773) 773
captopril (765) 765
health aspects (760) 760
heart-failure (759) 759
enzymes (755) 755
medicine, general & internal (736) 736
drug therapy (733) 733
heart rate - drug effects (727) 727
kidney (720) 720
angiotensin-ii (713) 713
myocardial-infarction (704) 704
hypertension - metabolism (699) 699
kidney - metabolism (697) 697
hypertension - complications (693) 693
rodents (691) 691
mortality (684) 684
analysis (683) 683
heart failure - physiopathology (682) 682
tetrazoles - pharmacology (675) 675
renin-angiotensin-aldosterone system (671) 671
angiotensin-converting enzyme inhibitors (660) 660
nephrology (645) 645
medicine, research & experimental (634) 634
receptor (602) 602
angiotensin ii - physiology (599) 599
inhibition (599) 599
inflammation (597) 597
internal medicine (593) 593
angiotensin ii - blood (590) 590
kidney - physiopathology (576) 576
care and treatment (575) 575
article (569) 569
renin - antagonists & inhibitors (568) 568
angiotensin-converting enzyme (558) 558
rats, inbred shr (558) 558
cardiology (553) 553
biochemistry & molecular biology (551) 551
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15556) 15556
Japanese (186) 186
German (178) 178
French (149) 149
Russian (143) 143
Spanish (102) 102
Italian (66) 66
Chinese (65) 65
Polish (45) 45
Danish (21) 21
Hungarian (19) 19
Portuguese (19) 19
Dutch (15) 15
Ukrainian (11) 11
Romanian (10) 10
Czech (9) 9
Bulgarian (8) 8
Turkish (8) 8
Norwegian (6) 6
Swedish (5) 5
Finnish (4) 4
Hebrew (3) 3
Slovak (3) 3
Serbian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 2016, Volume 311, Issue 4, pp. H871 - H880
We previously reported that endoplasmic reticulum (ER) stress is induced in the subfornical organ (SFO) and the hypothalamic paraventricular nucleus (PVN) of... 
Heart failure | Brain | Sympathetic activity | Hypothalamic paraventricular nucleus | Mitogen-activated protein kinase | Subfornical organ | Endoplasmic reticulum stress | heart failure | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | INDUCED PHOSPHORYLATION | MYOCARDIAL-INFARCTION | ER STRESS | subfornical organ | KINASE | RATS | sympathetic activity | KAPPA-B | brain | endoplasmic reticulum stress | hypothalamic paraventricular nucleus | mitogen-activated protein kinase | UNFOLDED PROTEIN RESPONSE | PERIPHERAL VASCULAR DISEASE | UP-REGULATION | Cholagogues and Choleretics - pharmacology | Tumor Necrosis Factor-alpha - genetics | Heart Failure - physiopathology | Male | NF-KappaB Inhibitor alpha - genetics | Peptidyl-Dipeptidase A - drug effects | Interleukin-1beta - genetics | Sympathetic Nervous System - physiopathology | RNA, Messenger - metabolism | Activating Transcription Factor 6 - genetics | Subfornical Organ - drug effects | Brain - metabolism | Heat-Shock Proteins - genetics | Inflammation - metabolism | Receptor, Angiotensin, Type 1 - genetics | Cyclooxygenase 2 - genetics | p38 Mitogen-Activated Protein Kinases - metabolism | Real-Time Polymerase Chain Reaction | Echocardiography | Signal Transduction | Rats | Cyclooxygenase 2 - drug effects | Heart Failure - metabolism | Rats, Sprague-Dawley | Blotting, Western | Brain - drug effects | Tumor Necrosis Factor-alpha - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Endoplasmic Reticulum Stress | Paraventricular Hypothalamic Nucleus - metabolism | Infusions, Intraventricular | Mitogen-Activated Protein Kinases - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Interleukin-1beta - drug effects | Sympathetic Nervous System - drug effects | Mitogen-Activated Protein Kinase 1 - drug effects | X-Box Binding Protein 1 - drug effects | Sympathetic Nervous System - metabolism | Transcription Factor RelA - genetics | Activating Transcription Factor 6 - drug effects | Mitogen-Activated Protein Kinase 3 - drug effects | Taurochenodeoxycholic Acid - pharmacology | Peptidyl-Dipeptidase A - genetics | Renin-Angiotensin System | Receptor, Angiotensin, Type 1 - drug effects | RNA, Messenger - drug effects | Subfornical Organ - metabolism | Heat-Shock Proteins - drug effects | Activating Transcription Factor 4 - genetics | Activating Transcription Factor 4 - drug effects | NF-KappaB Inhibitor alpha - drug effects | Paraventricular Hypothalamic Nucleus - drug effects | p38 Mitogen-Activated Protein Kinases - drug effects | Animals | Transcription Factor RelA - drug effects | X-Box Binding Protein 1 - genetics | Mitogen-Activated Protein Kinases - metabolism | Physiological aspects | Cellular signal transduction | Endoplasmic reticulum | Health aspects | Mitogen-activated protein kinases | Signal transduction | Inflammation | Kinases | Index Medicus | Cardiovascular Neurohormonal Regulation
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | STRUCTURAL-FUNCTIONAL RELATIONSHIPS | CORTICAL INTERSTITIUM | BLOOD-PRESSURE CONTROL | EARLY NATURAL-HISTORY | RETINOPATHY | ANGIOTENSIN-CONVERTING ENZYME | NEPHROPATHY | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 3, pp. 211 - 221
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9752, pp. 1543 - 1551
Journal Article
Circulation, ISSN 0009-7322, 12/2008, Volume 118, Issue 24, pp. 2523 - 2532
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2009, Volume 54, Issue 6, pp. 505 - 512
Journal Article